Loading...
XSWX
AEVS
Market cap1.35bUSD
Dec 04, Last price  
12.90CHF
1D
1.98%
1Q
-4.44%
Jan 2017
0.78%
Name

Aevis Victoria SA

Chart & Performance

D1W1MN
XSWX:AEVS chart
P/E
—
P/S
1.08
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.80%
Rev. gr., 5y
7.70%
Revenues
1.01b
+10.51%
9,555,000120,073,000119,135,000128,834,000181,485,000200,818,000344,406,000454,669,000484,852,000508,093,000517,115,000582,505,000577,130,000697,234,000696,566,000823,256,0001,030,550,000914,363,0001,010,427,000
Net income
-3m
L-92.69%
-30,867,700-3,232,000164,0001,945,000-7,123,000471,0003,325,0008,675,0006,118,0003,770,0002,309,000-922,000-8,659,000163,195,000-31,795,000-4,265,00058,812,000-39,295,000-2,872,000
CFO
46m
+8.96%
846,0005,568,00010,508,0008,990,00013,601,00012,684,00013,136,00041,674,00018,631,00036,575,00055,600,00060,094,00016,387,00018,862,00023,770,00033,534,000114,300,00042,673,00046,498,000
Dividend
Sep 28, 20230.3 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Aevis Victoria SA engages in healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. The company operates through Hospitals, Hospitality, Telemedicine, and Real Estate segments. It operates 22 hospitals with 1,496 beds; manages with a total of 941 rooms with a total rentable surface of 188,109 sqm. It also provides telemedicine, and ambulance and day clinic services. In addition, it engages in the patient hotel, better aging, radiology institute, pharmacy, ophthalmology, real estate management, stem cells, cosmetics, and publishing businesses, as well as organizes seminars. The company is headquartered in Fribourg, Switzerland. Aevis Victoria SA is a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.
URL
https://www.aevis.com/
IPO date
Jul 05, 1999
Employees
3,902
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT